In connection with the implementation of the project titled “ Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
In connection with the implementation of the project titled “ Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist…
In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious…
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological…
Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.
By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.